Welcome Guest | Register / Login

Bladder Cancer Market Research Reports

Sort By
Title Published Price
Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2018
By Delve Insight
"Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2018" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Non Muscle Invasive Bladder Cancer development. Th...
Jan 2018 $ 1250
Gallbladder Cancer - Pipeline Insight, 2018
By Delve Insight
"Gallbladder Cancer - Pipeline Insight, 2018" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gallbladder Cancer development. The report provides detailed cover...
Jan 2018 $ 1250
Global Bladder Cancer Partnering 2010 to 2017
By Current Partnering
"Delivery of this report will take 1-3 days after purchase." The Global Bladder Cancer Partnering since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leadi...
Nov 2017 $ 1495
The 2018-2023 World Outlook for Bladder Cancer Therapeutics
By ICON Group International, Inc.
This study covers the world outlook for bladder cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o...
Apr 2017 $ 995
The 2013-2018 Outlook for Bladder Cancer Therapeutics in Greater China
By ICON Group International, Inc.
This econometric study covers the latent demand outlook for bladder cancer therapeutics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing,...
Jan 2013 $ 495
The 2011-2016 World Outlook for Bladder Cancer Therapeutics
By ICON Group International, Inc.
This econometric study covers the world outlook for bladder cancer therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q...
Jan 2011 $ 795
The 2011-2016 Outlook for Bladder Cancer Therapeutics in Greater China
By ICON Group International, Inc.
This econometric study covers the latent demand outlook for bladder cancer therapeutics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (B...
Jan 2011 $ 495
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy